About the conference
The aim of this biennial meeting is to promote discussion and share new findings between researchers and clinicians for the benefit of patients infected by human T-lymphotropic virus (HTLV). HTLV infects approximately 15-20 million individuals worldwide and causes a broad spectrum of diseases including neurodegeneration and leukemia. Due to the recent exciting discoveries in this field, a particular session will focus on endogenous retroviruses, foamy viruses and XMRV.
Read more>>
But De Meirleir must present his findings on XMRV a day after the conference on june 9th!
ReplyDelete